Global Prostate Cancer Diagnostics Competitive Landscape Professional Research Report 2025
Market Overview
According to DIResearch's in-depth investigation and research, the global Prostate Cancer Diagnostics market size will reach 18,149 Million USD in 2025 and is projected to reach 31,468 Million USD by 2032, with a CAGR of 8.18% (2025-2032). Notably, the China Prostate Cancer Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Prostate cancer diagnostics encompass a range of medical procedures and tests aimed at identifying and characterizing prostate cancer. Common diagnostic tools include prostate-specific antigen (PSA) blood tests, digital rectal examinations (DRE), and imaging studies such as transrectal ultrasound (TRUS) or magnetic resonance imaging (MRI). Elevated PSA levels or abnormal findings during a DRE may prompt further investigation. Prostate biopsies, often guided by imaging techniques, involve the collection of tissue samples from the prostate for pathological examination to confirm the presence of cancer cells and determine the cancer's grade and extent. Advanced diagnostic methods may involve genomic testing to assess the genetic characteristics of the cancer cells. These diagnostic approaches help healthcare professionals stratify the risk, plan appropriate treatments, and monitor the progression of prostate cancer. As the field of prostate cancer diagnostics evolves, efforts focus on enhancing the accuracy of early detection, reducing unnecessary interventions, and personalizing treatment strategies based on the individual characteristics of the disease.
The major global suppliers of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Prostate Cancer Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Prostate Cancer Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Prostate Cancer Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Prostate Cancer Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Prostate Cancer Diagnostics Include:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Prostate Cancer Diagnostics Product Segment Include:
Tumor Biomarker Tests
Imaging
Biopsy
Other
Prostate Cancer Diagnostics Product Application Include:
Age Below 55
Age 55-75
Age Above 75
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Prostate Cancer Diagnostics Industry PESTEL Analysis
Chapter 3: Global Prostate Cancer Diagnostics Industry Porter’s Five Forces Analysis
Chapter 4: Global Prostate Cancer Diagnostics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Prostate Cancer Diagnostics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Prostate Cancer Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Prostate Cancer Diagnostics market size will reach 18,149 Million USD in 2025 and is projected to reach 31,468 Million USD by 2032, with a CAGR of 8.18% (2025-2032). Notably, the China Prostate Cancer Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Prostate cancer diagnostics encompass a range of medical procedures and tests aimed at identifying and characterizing prostate cancer. Common diagnostic tools include prostate-specific antigen (PSA) blood tests, digital rectal examinations (DRE), and imaging studies such as transrectal ultrasound (TRUS) or magnetic resonance imaging (MRI). Elevated PSA levels or abnormal findings during a DRE may prompt further investigation. Prostate biopsies, often guided by imaging techniques, involve the collection of tissue samples from the prostate for pathological examination to confirm the presence of cancer cells and determine the cancer's grade and extent. Advanced diagnostic methods may involve genomic testing to assess the genetic characteristics of the cancer cells. These diagnostic approaches help healthcare professionals stratify the risk, plan appropriate treatments, and monitor the progression of prostate cancer. As the field of prostate cancer diagnostics evolves, efforts focus on enhancing the accuracy of early detection, reducing unnecessary interventions, and personalizing treatment strategies based on the individual characteristics of the disease.
The major global suppliers of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health, DiaSorin, Myriad Genetics, Ambry Genetics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Prostate Cancer Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Prostate Cancer Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Prostate Cancer Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Prostate Cancer Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Prostate Cancer Diagnostics Include:
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Prostate Cancer Diagnostics Product Segment Include:
Tumor Biomarker Tests
Imaging
Biopsy
Other
Prostate Cancer Diagnostics Product Application Include:
Age Below 55
Age 55-75
Age Above 75
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Prostate Cancer Diagnostics Industry PESTEL Analysis
Chapter 3: Global Prostate Cancer Diagnostics Industry Porter’s Five Forces Analysis
Chapter 4: Global Prostate Cancer Diagnostics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Prostate Cancer Diagnostics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Prostate Cancer Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Prostate Cancer Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
1 PROSTATE CANCER DIAGNOSTICS MARKET OVERVIEW
1.1 Product Definition and Statistica Sclope
1.2 Prostate Cancer Diagnostics Product by Type
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Prostate Cancer Diagnostics Product by Application
1.3.1 Age Below 55
1.3.2 Age 55-75
1.3.3 Age Above 75
1.4 Global Prostate Cancer Diagnostics Market Size Analysis (2020-2032)
1.5 Prostate Cancer Diagnostics Market Development Status and Trends
1.5.1 Prostate Cancer Diagnostics Industry Development Status Analysis
1.5.2 Prostate Cancer Diagnostics Industry Development Trends Analysis
2 PROSTATE CANCER DIAGNOSTICS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 PROSTATE CANCER DIAGNOSTICS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY REGIONS
4.1 Global Prostate Cancer Diagnostics Overall Market: 2024 VS 2025 VS 2032
4.2 Global Prostate Cancer Diagnostics Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Prostate Cancer Diagnostics Revenue and Market Share by Region (2020-2025)
4.2.2 Global Prostate Cancer Diagnostics Revenue and Market Share Forecast by Region (2026-2032)
5 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Prostate Cancer Diagnostics Market Size by Type (2020-2032)
5.2 Global Prostate Cancer Diagnostics Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Prostate Cancer Diagnostics Market Size by Type
6.4 North America Prostate Cancer Diagnostics Market Size by Application
6.5 North America Prostate Cancer Diagnostics Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Prostate Cancer Diagnostics Market Size by Type
7.4 Europe Prostate Cancer Diagnostics Market Size by Application
7.5 Europe Prostate Cancer Diagnostics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Prostate Cancer Diagnostics Market Size by Type
8.4 China Prostate Cancer Diagnostics Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Type
9.4 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Application
9.5 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Prostate Cancer Diagnostics Market Size by Type
10.4 Latin America Prostate Cancer Diagnostics Market Size by Application
10.5 Latin America Prostate Cancer Diagnostics Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type
11.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application
11.5 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Prostate Cancer Diagnostics Market Revenue by Key Suppliers (2021-2025)
12.2 Prostate Cancer Diagnostics Competitive Landscape Analysis and Market Dynamic
12.2.1 Prostate Cancer Diagnostics Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 OPKO
13.1.1 OPKO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 OPKO Prostate Cancer Diagnostics Product Portfolio
13.1.3 OPKO Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Genomic Health
13.2.1 Genomic Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Genomic Health Prostate Cancer Diagnostics Product Portfolio
13.2.3 Genomic Health Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Abbott
13.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Abbott Prostate Cancer Diagnostics Product Portfolio
13.3.3 Abbott Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Beckman Coulter
13.4.1 Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
13.4.3 Beckman Coulter Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Siemens Healthcare
13.5.1 Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
13.5.3 Siemens Healthcare Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 bioMeriux
13.6.1 bioMeriux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 bioMeriux Prostate Cancer Diagnostics Product Portfolio
13.6.3 bioMeriux Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Roche
13.7.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Roche Prostate Cancer Diagnostics Product Portfolio
13.7.3 Roche Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 MDx Health
13.8.1 MDx Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 MDx Health Prostate Cancer Diagnostics Product Portfolio
13.8.3 MDx Health Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 DiaSorin
13.9.1 DiaSorin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 DiaSorin Prostate Cancer Diagnostics Product Portfolio
13.9.3 DiaSorin Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Myriad Genetics
13.10.1 Myriad Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
13.10.3 Myriad Genetics Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Ambry Genetics
13.11.1 Ambry Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
13.11.3 Ambry Genetics Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Prostate Cancer Diagnostics Industry Chain Analysis
14.2 Prostate Cancer Diagnostics Typical Downstream Customers
14.3 Prostate Cancer Diagnostics Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
1.1 Product Definition and Statistica Sclope
1.2 Prostate Cancer Diagnostics Product by Type
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Prostate Cancer Diagnostics Product by Application
1.3.1 Age Below 55
1.3.2 Age 55-75
1.3.3 Age Above 75
1.4 Global Prostate Cancer Diagnostics Market Size Analysis (2020-2032)
1.5 Prostate Cancer Diagnostics Market Development Status and Trends
1.5.1 Prostate Cancer Diagnostics Industry Development Status Analysis
1.5.2 Prostate Cancer Diagnostics Industry Development Trends Analysis
2 PROSTATE CANCER DIAGNOSTICS MARKET PESTEL ANALYSIS
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 PROSTATE CANCER DIAGNOSTICS MARKET PORTER'S FIVE FORCES ANALYSIS
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY REGIONS
4.1 Global Prostate Cancer Diagnostics Overall Market: 2024 VS 2025 VS 2032
4.2 Global Prostate Cancer Diagnostics Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Prostate Cancer Diagnostics Revenue and Market Share by Region (2020-2025)
4.2.2 Global Prostate Cancer Diagnostics Revenue and Market Share Forecast by Region (2026-2032)
5 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE BY TYPE AND APPLICATION
5.1 Global Prostate Cancer Diagnostics Market Size by Type (2020-2032)
5.2 Global Prostate Cancer Diagnostics Market Size by Application (2020-2032)
6 NORTH AMERICA
6.1 North America Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Suppliers Analysis
6.3 North America Prostate Cancer Diagnostics Market Size by Type
6.4 North America Prostate Cancer Diagnostics Market Size by Application
6.5 North America Prostate Cancer Diagnostics Market Size by Country
6.5.1 US
6.5.2 Canada
7 EUROPE
7.1 Europe Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Suppliers Analysis
7.3 Europe Prostate Cancer Diagnostics Market Size by Type
7.4 Europe Prostate Cancer Diagnostics Market Size by Application
7.5 Europe Prostate Cancer Diagnostics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 CHINA
8.1 China Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Suppliers Analysis
8.3 China Prostate Cancer Diagnostics Market Size by Type
8.4 China Prostate Cancer Diagnostics Market Size by Application
9 APAC (EXCL. CHINA)
9.1 APAC (excl. China) Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Suppliers Analysis
9.3 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Type
9.4 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Application
9.5 APAC (excl. China) Prostate Cancer Diagnostics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 LATIN AMERICA
10.1 Latin America Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Suppliers Analysis
10.3 Latin America Prostate Cancer Diagnostics Market Size by Type
10.4 Latin America Prostate Cancer Diagnostics Market Size by Application
10.5 Latin America Prostate Cancer Diagnostics Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Suppliers Analysis
11.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type
11.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application
11.5 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 COMPETITION BY SUPPLIERS
12.1 Global Prostate Cancer Diagnostics Market Revenue by Key Suppliers (2021-2025)
12.2 Prostate Cancer Diagnostics Competitive Landscape Analysis and Market Dynamic
12.2.1 Prostate Cancer Diagnostics Competitive Landscape Analysis
12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 KEY COMPANIES ANALYSIS
13.1 OPKO
13.1.1 OPKO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 OPKO Prostate Cancer Diagnostics Product Portfolio
13.1.3 OPKO Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Genomic Health
13.2.1 Genomic Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Genomic Health Prostate Cancer Diagnostics Product Portfolio
13.2.3 Genomic Health Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Abbott
13.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Abbott Prostate Cancer Diagnostics Product Portfolio
13.3.3 Abbott Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Beckman Coulter
13.4.1 Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
13.4.3 Beckman Coulter Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Siemens Healthcare
13.5.1 Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
13.5.3 Siemens Healthcare Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 bioMeriux
13.6.1 bioMeriux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 bioMeriux Prostate Cancer Diagnostics Product Portfolio
13.6.3 bioMeriux Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 Roche
13.7.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Roche Prostate Cancer Diagnostics Product Portfolio
13.7.3 Roche Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 MDx Health
13.8.1 MDx Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 MDx Health Prostate Cancer Diagnostics Product Portfolio
13.8.3 MDx Health Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 DiaSorin
13.9.1 DiaSorin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 DiaSorin Prostate Cancer Diagnostics Product Portfolio
13.9.3 DiaSorin Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Myriad Genetics
13.10.1 Myriad Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
13.10.3 Myriad Genetics Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Ambry Genetics
13.11.1 Ambry Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
13.11.3 Ambry Genetics Prostate Cancer Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 INDUSTRY CHAIN ANALYSIS
14.1 Prostate Cancer Diagnostics Industry Chain Analysis
14.2 Prostate Cancer Diagnostics Typical Downstream Customers
14.3 Prostate Cancer Diagnostics Sales Channel Analysis
15 RESEARCH FINDINGS AND CONCLUSION
16 METHODOLOGY AND DATA SOURCE
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer
LIST OF TABLES
Table 1: Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Prostate Cancer Diagnostics Industry Development Status
Table 4: Prostate Cancer Diagnostics Industry Development Trends
Table 5: Global Prostate Cancer Diagnostics Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Prostate Cancer Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Prostate Cancer Diagnostics Revenue Market Share by Region (2020-2025)
Table 8: Global Prostate Cancer Diagnostics Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Prostate Cancer Diagnostics Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Prostate Cancer Diagnostics Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Prostate Cancer Diagnostics Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Prostate Cancer Diagnostics Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Prostate Cancer Diagnostics Players in North America
Table 15: North America Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Prostate Cancer Diagnostics Players in Europe
Table 22: Europe Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Prostate Cancer Diagnostics Players in China
Table 29: China Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Prostate Cancer Diagnostics Players in APAC (excl. China)
Table 34: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Prostate Cancer Diagnostics Players in Latin America
Table 41: Latin America Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Prostate Cancer Diagnostics Players in Middle East & Africa
Table 48: Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Prostate Cancer Diagnostics Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Prostate Cancer Diagnostics Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: OPKO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: OPKO Prostate Cancer Diagnostics Product Portfolio
Table 60: OPKO Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: Genomic Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: Genomic Health Prostate Cancer Diagnostics Product Portfolio
Table 63: Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: Abbott Prostate Cancer Diagnostics Product Portfolio
Table 66: Abbott Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
Table 69: Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
Table 72: Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: bioMeriux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: bioMeriux Prostate Cancer Diagnostics Product Portfolio
Table 75: bioMeriux Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Roche Prostate Cancer Diagnostics Product Portfolio
Table 78: Roche Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: MDx Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: MDx Health Prostate Cancer Diagnostics Product Portfolio
Table 81: MDx Health Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: DiaSorin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: DiaSorin Prostate Cancer Diagnostics Product Portfolio
Table 84: DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Myriad Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
Table 87: Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: Ambry Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 89: Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
Table 90: Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 91: Prostate Cancer Diagnostics Typical Customer List
Table 92: Prostate Cancer Diagnostics Distributors List
Table 1: Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2024 VS 2025 VS 2032 (US$ Million)
Table 2: Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2024 VS 2025 VS 2032 (US$ Million)
Table 3: Prostate Cancer Diagnostics Industry Development Status
Table 4: Prostate Cancer Diagnostics Industry Development Trends
Table 5: Global Prostate Cancer Diagnostics Market Size by Region in US$ Million: 2024 VS 2025 VS 2032
Table 6: Global Prostate Cancer Diagnostics Revenue by Region (2020-2025) & (US$ Million)
Table 7: Global Prostate Cancer Diagnostics Revenue Market Share by Region (2020-2025)
Table 8: Global Prostate Cancer Diagnostics Revenue Forecast by Region (2026-2032) & (US$ Million)
Table 9: Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Region (2026-2032)
Table 10: Global Prostate Cancer Diagnostics Revenue Analysis by Type (2020-2025) & (US$ Million)
Table 11: Global Prostate Cancer Diagnostics Revenue Analysis Forecast by Type (2026-2032) & (US$ Million)
Table 12: Global Prostate Cancer Diagnostics Revenue Analysis by Application (2020-2025) & (US$ Million)
Table 13: Global Prostate Cancer Diagnostics Revenue Analysis Forecast by Application (2026-2032) & (US$ Million)
Table 14: Key Prostate Cancer Diagnostics Players in North America
Table 15: North America Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 16: North America Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 17: North America Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 18: North America Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 19: North America Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 20: North America Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 21: Key Prostate Cancer Diagnostics Players in Europe
Table 22: Europe Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 23: Europe Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 24: Europe Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 25: Europe Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 26: Europe Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 27: Europe Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 28: Key Prostate Cancer Diagnostics Players in China
Table 29: China Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 30: China Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 31: China Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 32: China Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 33: Key Prostate Cancer Diagnostics Players in APAC (excl. China)
Table 34: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 35: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 36: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 37: APAC (excl. China) Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 38: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 39: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 40: Key Prostate Cancer Diagnostics Players in Latin America
Table 41: Latin America Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 42: Latin America Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 43: Latin America Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 44: Latin America Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 45: Latin America Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 46: Latin America Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 47: Key Prostate Cancer Diagnostics Players in Middle East & Africa
Table 48: Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2020-2025) & (US$ Million)
Table 49: Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2026-2032) & (US$ Million)
Table 50: Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2020-2025) & (US$ Million)
Table 51: Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2026-2032) & (US$ Million)
Table 52: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Size by Country (2020-2025) & (US$ Million)
Table 53: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Size by Country (2026-2032) & (US$ Million)
Table 54: Global Prostate Cancer Diagnostics Market Revenue by Key Suppliers (2021-2025) & (US$ Million)
Table 55: Global Prostate Cancer Diagnostics Revenue Market Share by Key Suppliers (2021-2025)
Table 56: Global Key Suppliers Headquarter Location and Key Area Sales
Table 57: Market Mergers & Acquisitions, Expansion
Table 58: OPKO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 59: OPKO Prostate Cancer Diagnostics Product Portfolio
Table 60: OPKO Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 61: Genomic Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 62: Genomic Health Prostate Cancer Diagnostics Product Portfolio
Table 63: Genomic Health Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 64: Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 65: Abbott Prostate Cancer Diagnostics Product Portfolio
Table 66: Abbott Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 67: Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 68: Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
Table 69: Beckman Coulter Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 70: Siemens Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 71: Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
Table 72: Siemens Healthcare Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 73: bioMeriux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 74: bioMeriux Prostate Cancer Diagnostics Product Portfolio
Table 75: bioMeriux Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 76: Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 77: Roche Prostate Cancer Diagnostics Product Portfolio
Table 78: Roche Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 79: MDx Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 80: MDx Health Prostate Cancer Diagnostics Product Portfolio
Table 81: MDx Health Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 82: DiaSorin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 83: DiaSorin Prostate Cancer Diagnostics Product Portfolio
Table 84: DiaSorin Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 85: Myriad Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 86: Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
Table 87: Myriad Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 88: Ambry Genetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
Table 89: Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
Table 90: Ambry Genetics Prostate Cancer Diagnostics Revenue (US$ Million), Gross Margin and Market Share (2021-2025)
Table 91: Prostate Cancer Diagnostics Typical Customer List
Table 92: Prostate Cancer Diagnostics Distributors List
LIST OF FIGURES
Figure 1: Prostate Cancer Diagnostics Product Pictures
Figure 2: Tumor Biomarker Tests Picture Scope
Figure 3: Imaging Picture Scope
Figure 4: Biopsy Picture Scope
Figure 5: Other Picture Scope
Figure 6: Age Below 55 Picture Scope
Figure 7: Age 55-75 Picture Scope
Figure 8: Age Above 75 Picture Scope
Figure 9: Global Prostate Cancer Diagnostics Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 10: Global Prostate Cancer Diagnostics Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 11: Global Prostate Cancer Diagnostics Market Size by Region (2020-2032) & (US$ Million)
Figure 12: Global Prostate Cancer Diagnostics Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 13: North America Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 14: North America Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 15: North America Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 16: North America Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 17: US Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 18: Canada Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 19: Europe Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 20: Europe Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 21: Europe Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 22: Europe Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 23: Germany Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 24: France Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 25: United Kingdom Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 26: Italy Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 27: Spain Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 28: Benelux Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 29: China Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 30: China Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 31: China Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 32: China Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 33: APAC (excl. China) Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 34: APAC (excl. China) Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 35: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 36: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 37: Japan Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 38: South Korea Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 39: India Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 40: Australia Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 41: Southeast Asia Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 42: Latin America Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 43: Latin America Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 44: Latin America Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 45: Latin America Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 46: Mexico Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 47: Brazil Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 48: Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 49: Middle East & Africa Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 50: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 51: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 52: Saudi Arabia Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 53: South Africa Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 54: Global Prostate Cancer Diagnostics Revenue Market Share by Key Suppliers in 2024
Figure 55: Global Prostate Cancer Diagnostics Industry Competition Landscape
Figure 56: Prostate Cancer Diagnostics Industry Chain Analysis
Figure 57: Bottom-Up and Top-Down Research Methods
Figure 58: Key Interview Objectives
Figure 59: Data Cross Validation
Figure 1: Prostate Cancer Diagnostics Product Pictures
Figure 2: Tumor Biomarker Tests Picture Scope
Figure 3: Imaging Picture Scope
Figure 4: Biopsy Picture Scope
Figure 5: Other Picture Scope
Figure 6: Age Below 55 Picture Scope
Figure 7: Age 55-75 Picture Scope
Figure 8: Age Above 75 Picture Scope
Figure 9: Global Prostate Cancer Diagnostics Market Size Analysis: 2024 VS 2025 VS 2032 (US$ Million)
Figure 10: Global Prostate Cancer Diagnostics Market Revenue and Growth Rate Analysis: (2020-2032) & (US$ Million)
Figure 11: Global Prostate Cancer Diagnostics Market Size by Region (2020-2032) & (US$ Million)
Figure 12: Global Prostate Cancer Diagnostics Market Share Scenario by Region in Percentage: 2025 Versus 2032
Figure 13: North America Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 14: North America Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 15: North America Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 16: North America Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 17: US Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 18: Canada Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 19: Europe Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 20: Europe Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 21: Europe Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 22: Europe Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 23: Germany Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 24: France Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 25: United Kingdom Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 26: Italy Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 27: Spain Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 28: Benelux Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 29: China Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 30: China Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 31: China Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 32: China Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 33: APAC (excl. China) Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 34: APAC (excl. China) Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 35: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 36: APAC (excl. China) Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 37: Japan Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 38: South Korea Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 39: India Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 40: Australia Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 41: Southeast Asia Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 42: Latin America Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 43: Latin America Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 44: Latin America Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 45: Latin America Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 46: Mexico Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 47: Brazil Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 48: Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth Rate (2020-2032) & (US$ Million)
Figure 49: Middle East & Africa Prostate Cancer Diagnostics Market Share by Players in 2024
Figure 50: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Type (2020-2032)
Figure 51: Middle East & Africa Prostate Cancer Diagnostics Revenue Market Share by Application (2020-2032)
Figure 52: Saudi Arabia Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 53: South Africa Prostate Cancer Diagnostics Revenue (2020-2032) & (US$ Million)
Figure 54: Global Prostate Cancer Diagnostics Revenue Market Share by Key Suppliers in 2024
Figure 55: Global Prostate Cancer Diagnostics Industry Competition Landscape
Figure 56: Prostate Cancer Diagnostics Industry Chain Analysis
Figure 57: Bottom-Up and Top-Down Research Methods
Figure 58: Key Interview Objectives
Figure 59: Data Cross Validation
